相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Transcriptional Link between HER2, JAM-A and FOXA1 in Breast Cancer
Rodrigo G. B. Cruz et al.
CELLS (2022)
Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
Maria Castaneda et al.
CANCER RESEARCH (2022)
Epidemiology of breast cancer, a paradigm of the common soil hypothesis
Licia Iacoviello et al.
SEMINARS IN CANCER BIOLOGY (2021)
FOXA1 is a determinant of drug resistance in breast cancer cells
Uttom Kumar et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Time-varying effects of FOXA1 on breast cancer prognosis
Qian-xin Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1
Rodrigo G. B. Cruz et al.
CANCERS (2021)
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036
Steven P. Angus et al.
NPJ BREAST CANCER (2021)
FOXA1 overexpression suppresses interferon signaling and immune response in cancer
Yundong He et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers
Luke J. Nelson et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and Breast Cancer Survival
Jung S. Byun et al.
CLINICAL CANCER RESEARCH (2020)
Roles and correlation of FOXA1 and ZIC1 in breast cancer
Yu-wei Zhang et al.
CURRENT PROBLEMS IN CANCER (2020)
Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3
Motoki Takaku et al.
NUCLEIC ACIDS RESEARCH (2020)
High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer
Yoshiya Horimoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Foxa1 and Foxa2 orchestrate development of the urethral tube and division of the embryonic cloaca through an autoregulatory loop with Shh
Marissa L. Gredler et al.
DEVELOPMENTAL BIOLOGY (2020)
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014)
Shahin De Lara et al.
BMC CANCER (2019)
Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series
A. C. Picornell et al.
BMC GENOMICS (2019)
Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?
Anita Mangia et al.
CANCERS (2019)
Androgen receptor and FOXA1 coexpression define a luminal-AR subtype of feline mammary carcinomas, spontaneous models of breast cancer
Elie Dagher et al.
BMC CANCER (2019)
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
Xiaoyong Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study
Jamie R. Kutasovic et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
FOXA1 is Prognostic of Triple Negative Breast Cancers by Transcriptionally Suppressing SOD2 and IL6
Xiaofeng Dai et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
Nelson Rangel et al.
BMC CANCER (2018)
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers
Severine Guiu et al.
BRITISH JOURNAL OF CANCER (2018)
Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease
Ruiqin Mai et al.
HUMAN PATHOLOGY (2018)
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome
Willemijne Schrijver et al.
MOLECULAR ONCOLOGY (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
The Dominant Role of Forkhead Box Proteins in Cancer
Duc-Hiep Bach et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy
Kimihiro Tanaka et al.
BREAST CANCER (2017)
FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
Shujiao He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression
Li-Li Wang et al.
TUMOR BIOLOGY (2017)
Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
Ayako Nakashoji et al.
ONCOLOGY LETTERS (2017)
Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers
Seho Park et al.
ONCOTARGET (2017)
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
Matthew P. Humphries et al.
SCIENTIFIC REPORTS (2017)
FOXA1 Induces E-Cadherin Expression at the Protein Level via Suppression of Slug in Epithelial Breast Cancer Cells
Erina Anzai et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Pathobiology of the 129:Stat1-/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype
Hidetoshi Mori et al.
BREAST CANCER RESEARCH (2017)
Prognostic value of FOXA1 in breast cancer: A systematic review and meta-analysis
Jiafeng Shou et al.
BREAST (2016)
GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas
Drew G. Davis et al.
HUMAN PATHOLOGY (2016)
FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function
Yeqing A. Yang et al.
NUCLEIC ACIDS RESEARCH (2016)
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
Xiaoyong Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
Felipe Slebe et al.
NATURE COMMUNICATIONS (2016)
FOXA1 defines cancer cell specificity
Gaihua Zhang et al.
SCIENCE ADVANCES (2016)
FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients
Chenpu Xu et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals
Xiao-Lin Zhang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Brett Wallden et al.
BMC MEDICAL GENOMICS (2015)
Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial
Severine Guiu et al.
FUTURE ONCOLOGY (2015)
Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases
Y. Horimoto et al.
BRITISH JOURNAL OF CANCER (2015)
FOXA1: a Promising Prognostic Marker in Breast Cancer
Qing Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1
Sagar Ghosh et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
FOXA1 represses the molecular phenotype of basal breast cancer cells
G. M. Bernardo et al.
ONCOGENE (2013)
Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer
Yuichi Hisamatsu et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
FOXA1: a transcription factor with parallel functions in development and cancer
Gina M. Bernardo et al.
BIOSCIENCE REPORTS (2012)
FOXA1 is an independent prognostic marker for ER-positive breast cancer
Rutika J. Mehta et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients
Nobuhiro Ijichi et al.
HORMONES & CANCER (2012)
Cross-regulation between FOXA1 and ErbB2 Signaling in Estrogen Receptor-Negative Breast Cancer
Ali Naderi et al.
NEOPLASIA (2012)
FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
Jessica L. L. Robinson et al.
Frontiers in Endocrinology (2012)
Pioneer factors in hormone-dependent cancers
Kamila M. Jozwik et al.
NATURE REVIEWS CANCER (2012)
Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer
Chunpeng Zhang et al.
CANCER RESEARCH (2011)
FOXA1: master of steroid receptor function in cancer
Michael A. Augello et al.
EMBO JOURNAL (2011)
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
Jessica L. L. Robinson et al.
EMBO JOURNAL (2011)
Pioneer transcription factors: establishing competence for gene expression
Kenneth S. Zaret et al.
GENES & DEVELOPMENT (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
Yan Song et al.
CANCER RESEARCH (2010)
FOXA1 is an essential determinant of ERα expression and mammary ductal morphogenesis
Gina M. Bernardo et al.
DEVELOPMENT (2010)
Expression of Forkhead- box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores
Foluso O. Ademuyiwa et al.
MODERN PATHOLOGY (2010)
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
Leo A. Niemeier et al.
MODERN PATHOLOGY (2010)
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
Andre Albergaria et al.
BREAST CANCER RESEARCH (2009)
A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer
Ali Naderi et al.
NEOPLASIA (2008)
FOXA1 expression in breast cancer - Correlation with luminal subtype A and survival
Sunil Badve et al.
CLINICAL CANCER RESEARCH (2007)
FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer
Ido Wolf et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland
Hosein Kouros-Mehr et al.
CELL (2006)
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer
Jerome Eeckhoute et al.
GENES & DEVELOPMENT (2006)
Estrogen receptor target gene: An evolving concept
Jason S. Carroll et al.
MOLECULAR ENDOCRINOLOGY (2006)
Expression and role of foxa proteins in prostate cancer
Janni Mirosevich et al.
PROSTATE (2006)
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1
EA Williamson et al.
ONCOGENE (2006)
Regulatory mechanisms controlling human E-cadherin gene expression
YN Liu et al.
ONCOGENE (2005)
分享论文
